XT
LTRN icon

XTX Topco’s Lantern Pharma LTRN Stock Holding History

XTX Topco’s Portfolio LTRN Stock Details LTRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$72.6K Buy
+17,415
New +$51.1K ﹤0.01% 3623
2025
Q3 		– Sell
-12,624
Closed -$39.9K – 2959
2025
Q2 		$39.9K Buy
+12,624
New +$42.6K ﹤0.01% 2063

Other funds holding LTRN

EAM
Empery Asset Management New York $86.5M AUM
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return

XTX Topco's LTRN Position: Q2 2026 in Review

XTX Topco opened a new position in Lantern Pharma (LTRN) in Q2 2026: 17,415 shares worth $72.6K. The stake represents ﹤0.01% of the portfolio and ranks #3623 among its holdings. This is a return to the name: XTX Topco previously reported a position in LTRN as recently as Q2 2025.

XTX Topco first reported a position in LTRN in Q2 2025 and has held it in 2 quarters since. 39 funds tracked by Wall St. Rank hold LTRN as of Q2 2026.

  • XTX Topco held 17,415 shares of Lantern Pharma worth $72.6K as of Q2 2026.
  • Lantern Pharma was a new XTX Topco position in Q2 2026.
  • Lantern Pharma made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3623 holding.
  • XTX Topco first reported a position in Lantern Pharma in Q2 2025 and has held it in 2 quarters since.
  • 39 funds tracked by Wall St. Rank held Lantern Pharma as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.